These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1328925)

  • 1. Structural requirements for the effects of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
    Miura M; Inui A; Teranishi A; Hirosue Y; Nakajima M; Okita M; Inoue T; Baba S; Kasuga M
    Neuropeptides; 1992 Sep; 23(1):15-8. PubMed ID: 1328925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Life Sci; 1989; 44(15):1043-51. PubMed ID: 2538698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog].
    Inoue T; Inui A; Okita M; Sakatani N; Oya M; Morioka H; Mizuno N; Oimomi M; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1990 Jun; 66(6):607-18. PubMed ID: 2167247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine actions of central neuropeptide Y in the ewe: activation of the hypothalamo-pituitary-adrenal axis by exogenous neuropeptide Y and role of endogenous neuropeptide Y in the secretion of luteinizing hormone during the oestrous cycle.
    Porter DW; Naylor AM; McNeilly AS; Lincoln DW
    J Neuroendocrinol; 1993 Apr; 5(2):163-74. PubMed ID: 8485551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide-Y stimulates pituitary-adrenal activity in fetal and adult sheep.
    Brooks AN; Howe DC; Porter DW; Naylor AM
    J Neuroendocrinol; 1994 Apr; 6(2):161-6. PubMed ID: 8049713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain neuropeptide Y in the control of adrenocorticotropic hormone secretion in the dog.
    Inui A; Inoue T; Nakajima M; Okita M; Sakatani N; Okimura Y; Chihara K; Baba S
    Brain Res; 1990 Mar; 510(2):211-5. PubMed ID: 2158850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effect.
    Small CJ; Todd JF; Ghatei M; Smith DM; Bloom SR
    Regul Pept; 1998 Sep; 75-76():301-7. PubMed ID: 9802423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis.
    Hanson ES; Dallman MF
    J Neuroendocrinol; 1995 Apr; 7(4):273-9. PubMed ID: 7647769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.
    Small CJ; Morgan DG; Meeran K; Heath MM; Gunn I; Edwards CM; Gardiner J; Taylor GM; Hurley JD; Rossi M; Goldstone AP; O'Shea D; Smith DM; Ghatei MA; Bloom SR
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11686-91. PubMed ID: 9326671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP; Clarke IJ; Funder JW; Engler D
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat.
    Wahlestedt C; Skagerberg G; Ekman R; Heilig M; Sundler F; Håkanson R
    Brain Res; 1987 Aug; 417(1):33-8. PubMed ID: 3040184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N; Shibasaki T; Wakabayashi I; Demura H
    Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
    Härle P; Straub RH; Wiest R; Mayer A; Schölmerich J; Atzeni F; Carrabba M; Cutolo M; Sarzi-Puttini P
    Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin a stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity.
    Moreno G; Perelló M; Gaillard RC; Spinedi E
    Endocrine; 2005 Mar; 26(2):99-106. PubMed ID: 15888921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide in regulating the rat hypothalamic-pituitary-adrenal axis response to endotoxemia.
    Rivier C
    Ann N Y Acad Sci; 2003 May; 992():72-85. PubMed ID: 12794048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
    Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
    Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
    Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory interactions between alpha 2-adrenergic and opoid but not NPY mechanisms controlling the CRF-ACTH axis in the rat.
    Gaillet S; Malaval F; Barbanel G; Pelletier G; Assenmacher I; Szafarczyk A
    Regul Pept; 1991 Oct; 36(2):249-61. PubMed ID: 1666688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.